SPY378.65+2.95 0.79%
DIA309.32+1.20 0.39%
IXIC13,197.18+198.68 1.53%

GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to the FDA for Epidiolex for the Treatment of Tuberous Sclerosis Complex

Benzinga · 02/03/2020 12:10